Overview

Evaluate the Drug-drugs Interaction Between Lobeglitazone and Empagliflozin

Status:
Unknown status
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
This study is a randomized, open-label, multiple dosing, crossover study to evaluate the drug-drugs interaction between Lobeglitazone and Empagliflozin in healthy male volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Treatments:
Empagliflozin